SHANGYA TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.1 TWD | +9.95% |
|
-1.34% | -35.76% |
| Sales 2022 | 85.17M 2.61M 209M | Sales 2023 | 231M 7.09M 567M | Capitalization | 1.52B 46.74M 3.74B |
|---|---|---|---|---|---|
| Net income 2022 | 1M 30.67K 2.45M | Net income 2023 | -80M -2.45M -196M | EV / Sales 2022 | 12.6 x |
| Net cash position 2022 | 250M 7.66M 613M | Net cash position 2023 | 160M 4.9M 392M | EV / Sales 2023 | 5.9 x |
| P/E ratio 2022 |
997
x | P/E ratio 2023 |
-19
x | Employees | 31 |
| Yield 2022 * |
-
| Yield 2023 |
1.45% | Free-Float | 45.72% |
More Fundamentals
* Assessed data
More news
| 1 day | +9.95% | ||
| 1 week | -1.34% | ||
| Current month | -8.49% | ||
| 1 month | -8.49% | ||
| 3 months | -22.86% | ||
| 6 months | -35.94% | ||
| Current year | -35.76% |
1 week
19.60
22.35
1 month
19.6024.50
Current year
19.6035.60
1 year
19.6038.25
3 years
18.5055.40
5 years
18.5055.40
10 years
18.5076.80
| Managers | Title | Age | Since |
|---|---|---|---|
Kun Chien Huang
CEO | Chief Executive Officer | - | - |
Hsiao Ling Huang
DFI | Director of Finance/CFO | - | 28/02/10 |
Ssu Hsin Chang
PRN | Corporate Officer/Principal | - | 14/03/10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kun Chien Huang
CEO | Chief Executive Officer | - | - |
Hsing Han Liang
BRD | Director/Board Member | - | - |
Qi Min Chen
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 22.1 | +9.95% | 77,786 |
| 29/04/24 | 20.1 | -3.37% | 145,372 |
| 26/04/24 | 20.8 | -1.65% | 90,829 |
| 25/04/24 | 21.15 | -3.64% | 42,277 |
| 24/04/24 | 21.95 | -0.23% | 21,121 |
End-of-day quote Taipei Exchange, April 29, 2024
More quotes
Shangya Technology Co Ltd a Taiwan-based company engaged in the provision of Western medicine products. The businesses include Western medicine trading, solar power generation, real estate leasing, and power integrated circuit (IC) design, production, and sales. It sells products directly or through distributors to medical centers, public hospitals, foundation hospitals and clinics, pharmacies. It sells power to Taiwan power companies. The sales targets also include company line numbers and individuals. Products include nervous system drugs, antineoplastic drugs, hypoglycemic drugs, cardiovascular system drugs, respiratory drugs, sexual dysfunction drugs, non-infectious pain relievers and anti-inflammatory drugs and hepatitis drugs. Solar energy is used for electricity supply. Power ICs are used in mobile phones, tablet charging chips, Type C expansion houses, industrial control equipment, televisions, personal computers and notebook computers, automobiles and smart fan control.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -35.76% | 27.33M | |
| +16.03% | 70.45B | |
| +2.22% | 25.03B | |
| +7.11% | 8.29B | |
| -2.98% | 8.05B | |
| -20.55% | 7.97B | |
| +3.91% | 4.62B | |
| +17.12% | 4.25B | |
| -1.24% | 4.04B | |
| -3.44% | 3.86B |
- Stock Market
- Equities
- 6130 Stock
